See today's BioWorld
To read the full story, subscribe or sign in.

Skip the footnote, PhRMA tells FDA, advising stronger guidance for interchangeables

April 14, 2020
By Mari Serebrov
When it comes to guidance on interchangeables, the Pharmaceutical Research and Manufacturers of America (PhRMA) has some guidance for the FDA: Be more definite.
BioWorld Regulatory Biosimilar FDA